Safety and efficacy of the Toumai robotic assisted versus the DaVinci robotic assisted radical gastrectomy for patients with gastric cancer

托迈机器人辅助与达芬奇机器人辅助根治性胃切除术治疗胃癌患者的安全性和有效性比较

阅读:1

Abstract

BACKGROUND: Robot-assisted gastrectomy (RAG) is a promising alternative treatment for gastric cancer. However, the therapeutic efficacy of the Toumai system in RAG remains unexplored. This study aimed to analyzed the outcomes of the Toumai system versus the DaVinci system in RAG. METHODS: This was a retrospective propensity score-matched analysis from January 2022 and March 2024. Patients who underwent RAG using the Toumai system or DaVinci Xi system were enrolled and a propensity score-matched analysis was performed in a 1:1 manner. The patients were divided into Toumai group and DaVinci group. The clinicopathological characteristics and short-term outcomes were observed. RESULTS: After propensity score matching, 64 patients each in the Toumai and DaVinci groups. There was no statistical difference between the Toumai system and the DaVinci system in terms of short-term postoperative complications (15.6% vs. 12.5%, P = 1.0), and no serious complications occurred in either group. 2 cases had bleeding and 4 cases had abdominal infection and 4 cases had respiratory tract infection in the Toumai group. 4 cases had bleeding and 1 case had deep venous thrombosis and 2 cases had respiratory tract infection in the DaVinci group. No significant differences in other clinical parameters between the groups, such as operative time, number of retrieved lymph nodes, estimated intraoperative blood loss, first flatus, length of hospital stay, time to liquid diet, time to ambulation postoperatively, drainage volume on postoperative day 1, and pain scores from postoperative day 1 to day 3 (all P ≥ 0.05). CONCLUSION: Both the Toumai and DaVinci surgical systems demonstrate comparable clinical outcomes in RAG. The Toumai system offers a viable new option for the surgical management of gastric cancer.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。